Literature DB >> 19494569

Gene therapy for the inner ear: challenges and promises.

Allen F Ryan, Stefan Dazert.   

Abstract

Since the recognition of genes as the discrete units of heritability, and of DNA as their molecular substrate, the utilization of genes for therapeutic purposes has been recognized as a potential means of correcting genetic disorders. The tools of molecular biology, which allow the manipulation of DNA sequence, provided the means to put this concept into practice. However, progress in the implementation of these ideas has been slow. Here we review the history of the idea of gene therapy and the complexity of genetic disorders. We also discuss the requirements for sequence-based therapy to be accomplished for different types of inherited diseases, as well as the methods available for gene manipulation. The challenges that have limited the applications of gene therapy are reviewed, as are ethical concerns. Finally, we discuss the promise of gene therapy to address inherited and acquired disorders of the inner ear. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19494569      PMCID: PMC4332585          DOI: 10.1159/000218203

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  38 in total

1.  "Playing God": the ethics of biotechnical intervention.

Authors:  Andrew C Varga
Journal:  Thought       Date:  1985-06

2.  The perils of treading on heredity.

Authors:  Philip Elmer-Dewitt
Journal:  Time       Date:  1989-03-20

Review 3.  The potential role of endogenous stem cells in regeneration of the inner ear.

Authors:  Rodrigo Martinez-Monedero; Kazuo Oshima; Stefan Heller; Albert S B Edge
Journal:  Hear Res       Date:  2007-01-20       Impact factor: 3.208

4.  Incorporation of Heterologous Deoxyribonucleic Acid into Mammalian Cells.

Authors:  K G Bensch; D W King
Journal:  Science       Date:  1961-02-10       Impact factor: 47.728

Review 5.  Gene therapy of inherited diseases.

Authors:  Alain Fischer; Marina Cavazzana-Calvo
Journal:  Lancet       Date:  2008-06-14       Impact factor: 79.321

6.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

7.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

8.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 9.  Gene therapy for cystic fibrosis lung disease: current status and future perspectives.

Authors:  Josef Rosenecker; Stephanie Huth; Carsten Rudolph
Journal:  Curr Opin Mol Ther       Date:  2006-10

10.  Human cytomegalovirus IE1 promoter/enhancer drives variable gene expression in all fiber types in transgenic mouse skeletal muscle.

Authors:  P L Hallauer; K E Hastings
Journal:  BMC Genet       Date:  2000-10-04       Impact factor: 2.797

View more
  1 in total

1.  Hair cell stereociliary bundle regeneration by espin gene transduction after aminoglycoside damage and hair cell induction by Notch inhibition.

Authors:  A Taura; K Taura; Y Koyama; N Yamamoto; T Nakagawa; J Ito; A F Ryan
Journal:  Gene Ther       Date:  2016-03-10       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.